HUTCHMED (China) (HUTCHMED (China)) Operating Cash Flow per Share : $1.27 (TTM As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is HUTCHMED (China) Operating Cash Flow per Share?

HUTCHMED (China)'s operating cash flow per share for the six months ended in Dec. 2023 was $-0.04. HUTCHMED (China)'s operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.27.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for HUTCHMED (China)'s Operating Cash Flow per Share or its related term are showing as below:

During the past 13 years, HUTCHMED (China)'s highest 3-Year average Operating Cash Flow per Share Growth Rate was 12.60% per year. The lowest was -92.70% per year. And the median was -46.20% per year.

HCM's 3-Year OCF Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 8.2
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

HUTCHMED (China) Operating Cash Flow per Share Historical Data

The historical data trend for HUTCHMED (China)'s Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HUTCHMED (China) Operating Cash Flow per Share Chart

HUTCHMED (China) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.61

-0.45

-1.29

-1.59

1.26

HUTCHMED (China) Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.84	-0.53	-1.06	1.31	-0.04

Competitive Comparison of HUTCHMED (China)'s Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, HUTCHMED (China)'s Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HUTCHMED (China)'s Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HUTCHMED (China)'s Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where HUTCHMED (China)'s Price-to-Operating-Cash-Flow falls into.

HUTCHMED (China) Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

HUTCHMED (China)'s Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	219.258	/	173.839
	=	1.26

HUTCHMED (China)'s Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-7.145	/	174.280
	=	-0.04

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $1.27

HUTCHMED (China) Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of HUTCHMED (China)'s Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

HUTCHMED (China) (HUTCHMED (China)) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HUTCHMED (China) Ltd (NAS:HCM) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

00013:Hong Kong HCM.GB:UK HCM:UK H7T2:Germany

Address

2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG

Website

https://www.hutch-med.com

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.